Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
Coisne C, Mao W, Engelhardt B
J Immunol. 2009 May 15; 182(10):5909-13. PMID: 19414741.Abstract